Goldman Sachs Group Inc. Purchases 858,693 Shares of Astera Labs, Inc. $ALAB

Goldman Sachs Group Inc. grew its position in Astera Labs, Inc. (NASDAQ:ALAB) by 189.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 1,312,927 shares of the company’s stock after buying an additional 858,693 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Astera Labs were worth $218,419,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Assetmark Inc. raised its stake in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Hilltop National Bank raised its stake in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new position in Astera Labs in the 4th quarter worth approximately $33,000. Wexford Capital LP bought a new position in Astera Labs in the 3rd quarter worth approximately $39,000. Finally, National Bank of Canada FI raised its position in Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after purchasing an additional 124 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

ALAB opened at $317.06 on Friday. The company has a fifty day moving average price of $212.95 and a two-hundred day moving average price of $171.60. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $372.37. The firm has a market capitalization of $54.35 billion, a PE ratio of 214.23, a P/E/G ratio of 4.20 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the previous year, the business earned $0.33 EPS. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,311,256 shares of company stock worth $477,341,446 over the last quarter. 10.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Roth Mkm restated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Evercore restated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Royal Bank Of Canada boosted their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Barclays boosted their price objective on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $233.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.